nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2D6—Lomustine—brain cancer	0.144	0.496	CbGbCtD
Doxazosin—CYP2D6—Hydroxyurea—brain cancer	0.109	0.376	CbGbCtD
Doxazosin—ABCB1—Etoposide—brain cancer	0.0369	0.127	CbGbCtD
Doxazosin—KCNH6—ganglion—brain cancer	0.0159	0.124	CbGeAlD
Doxazosin—Donepezil—CYP2C9—brain cancer	0.00915	1	CrCbGaD
Doxazosin—KCNH6—telencephalon—brain cancer	0.00615	0.0478	CbGeAlD
Doxazosin—KCNH7—head—brain cancer	0.00537	0.0418	CbGeAlD
Doxazosin—KCNH7—central nervous system—brain cancer	0.0049	0.0382	CbGeAlD
Doxazosin—KCNH7—cerebellum—brain cancer	0.00479	0.0373	CbGeAlD
Doxazosin—KCNH7—brain—brain cancer	0.00389	0.0303	CbGeAlD
Doxazosin—ADRA1A—hindbrain—brain cancer	0.00385	0.0299	CbGeAlD
Doxazosin—KCNH6—head—brain cancer	0.00383	0.0298	CbGeAlD
Doxazosin—KCNH6—central nervous system—brain cancer	0.00349	0.0272	CbGeAlD
Doxazosin—ADRA1D—telencephalon—brain cancer	0.00341	0.0265	CbGeAlD
Doxazosin—KCNH6—brain—brain cancer	0.00277	0.0216	CbGeAlD
Doxazosin—CYP2D6—hindbrain—brain cancer	0.00227	0.0176	CbGeAlD
Doxazosin—ADRA1A—brainstem—brain cancer	0.0022	0.0171	CbGeAlD
Doxazosin—ADRA1B—head—brain cancer	0.00217	0.0169	CbGeAlD
Doxazosin—ADRA1D—endocrine gland—brain cancer	0.00215	0.0167	CbGeAlD
Doxazosin—ADRA1D—head—brain cancer	0.00212	0.0165	CbGeAlD
Doxazosin—ADRA1B—central nervous system—brain cancer	0.00198	0.0154	CbGeAlD
Doxazosin—ORM1—spinal cord—brain cancer	0.00197	0.0153	CbGeAlD
Doxazosin—ADRA1A—telencephalon—brain cancer	0.00196	0.0152	CbGeAlD
Doxazosin—ADRA1D—central nervous system—brain cancer	0.00194	0.0151	CbGeAlD
Doxazosin—KCNH2—telencephalon—brain cancer	0.00189	0.0147	CbGeAlD
Doxazosin—ORM1—endocrine gland—brain cancer	0.00177	0.0138	CbGeAlD
Doxazosin—ABCB1—blood vessel—brain cancer	0.00171	0.0133	CbGeAlD
Doxazosin—ORM1—central nervous system—brain cancer	0.00159	0.0124	CbGeAlD
Doxazosin—ADRA1B—brain—brain cancer	0.00157	0.0122	CbGeAlD
Doxazosin—KCNH2—pituitary gland—brain cancer	0.00154	0.012	CbGeAlD
Doxazosin—ADRA1D—brain—brain cancer	0.00154	0.012	CbGeAlD
Doxazosin—ADRA2A—telencephalon—brain cancer	0.00149	0.0116	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—brain cancer	0.00148	0.0115	CbGeAlD
Doxazosin—KCNH2—midbrain—brain cancer	0.00136	0.0106	CbGeAlD
Doxazosin—KCNH2—spinal cord—brain cancer	0.00132	0.0103	CbGeAlD
Doxazosin—CYP2D6—brainstem—brain cancer	0.0013	0.0101	CbGeAlD
Doxazosin—Anxiety—Procarbazine—brain cancer	0.00129	0.00247	CcSEcCtD
Doxazosin—Sweating increased—Temozolomide—brain cancer	0.00128	0.00246	CcSEcCtD
Doxazosin—Neutropenia—Carmustine—brain cancer	0.00127	0.00245	CcSEcCtD
Doxazosin—Bronchitis—Temozolomide—brain cancer	0.00127	0.00243	CcSEcCtD
Doxazosin—Dry mouth—Procarbazine—brain cancer	0.00126	0.00243	CcSEcCtD
Doxazosin—Cardiac failure—Etoposide—brain cancer	0.00125	0.0024	CcSEcCtD
Doxazosin—Confusional state—Procarbazine—brain cancer	0.00125	0.0024	CcSEcCtD
Doxazosin—CYP2C19—endocrine gland—brain cancer	0.00125	0.00972	CbGeAlD
Doxazosin—ADRA2A—gonad—brain cancer	0.00124	0.00966	CbGeAlD
Doxazosin—Vomiting—Lomustine—brain cancer	0.00124	0.00238	CcSEcCtD
Doxazosin—Oedema—Procarbazine—brain cancer	0.00124	0.00238	CcSEcCtD
Doxazosin—ADRA1A—endocrine gland—brain cancer	0.00123	0.0096	CbGeAlD
Doxazosin—Dysuria—Temozolomide—brain cancer	0.00123	0.00236	CcSEcCtD
Doxazosin—Neutropenia—Temozolomide—brain cancer	0.00123	0.00236	CcSEcCtD
Doxazosin—Infection—Procarbazine—brain cancer	0.00123	0.00236	CcSEcCtD
Doxazosin—Hyperglycaemia—Carmustine—brain cancer	0.00123	0.00236	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00122	0.00235	CcSEcCtD
Doxazosin—Pneumonia—Carmustine—brain cancer	0.00122	0.00235	CcSEcCtD
Doxazosin—Shock—Procarbazine—brain cancer	0.00122	0.00234	CcSEcCtD
Doxazosin—ADRA1A—head—brain cancer	0.00122	0.00948	CbGeAlD
Doxazosin—Pollakiuria—Temozolomide—brain cancer	0.00122	0.00234	CcSEcCtD
Doxazosin—Erectile dysfunction—Temozolomide—brain cancer	0.00121	0.00233	CcSEcCtD
Doxazosin—Thrombocytopenia—Procarbazine—brain cancer	0.00121	0.00233	CcSEcCtD
Doxazosin—Depression—Carmustine—brain cancer	0.00121	0.00233	CcSEcCtD
Doxazosin—ADRA2A—pituitary gland—brain cancer	0.00121	0.00942	CbGeAlD
Doxazosin—Chills—Hydroxyurea—brain cancer	0.00121	0.00232	CcSEcCtD
Doxazosin—Tachycardia—Procarbazine—brain cancer	0.00121	0.00232	CcSEcCtD
Doxazosin—Photosensitivity reaction—Temozolomide—brain cancer	0.0012	0.00231	CcSEcCtD
Doxazosin—Weight increased—Temozolomide—brain cancer	0.0012	0.0023	CcSEcCtD
Doxazosin—Hyperhidrosis—Procarbazine—brain cancer	0.0012	0.0023	CcSEcCtD
Doxazosin—Alopecia—Hydroxyurea—brain cancer	0.00119	0.00229	CcSEcCtD
Doxazosin—Weight decreased—Temozolomide—brain cancer	0.00119	0.00229	CcSEcCtD
Doxazosin—KCNH2—endocrine gland—brain cancer	0.00119	0.00927	CbGeAlD
Doxazosin—Hyperglycaemia—Temozolomide—brain cancer	0.00119	0.00228	CcSEcCtD
Doxazosin—Urinary tract infection—Carmustine—brain cancer	0.00118	0.00227	CcSEcCtD
Doxazosin—Pneumonia—Temozolomide—brain cancer	0.00118	0.00227	CcSEcCtD
Doxazosin—Anorexia—Procarbazine—brain cancer	0.00118	0.00227	CcSEcCtD
Doxazosin—KCNH2—head—brain cancer	0.00118	0.00915	CbGeAlD
Doxazosin—Depression—Temozolomide—brain cancer	0.00117	0.00225	CcSEcCtD
Doxazosin—ADRA2A—medulla oblongata—brain cancer	0.00117	0.00909	CbGeAlD
Doxazosin—Nausea—Lomustine—brain cancer	0.00116	0.00222	CcSEcCtD
Doxazosin—Hypotension—Procarbazine—brain cancer	0.00116	0.00222	CcSEcCtD
Doxazosin—CYP2D6—telencephalon—brain cancer	0.00115	0.00896	CbGeAlD
Doxazosin—Urinary tract infection—Temozolomide—brain cancer	0.00114	0.00219	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00113	0.00217	CcSEcCtD
Doxazosin—Insomnia—Procarbazine—brain cancer	0.00112	0.00215	CcSEcCtD
Doxazosin—Paraesthesia—Procarbazine—brain cancer	0.00111	0.00213	CcSEcCtD
Doxazosin—ADRA1A—central nervous system—brain cancer	0.00111	0.00865	CbGeAlD
Doxazosin—Sinusitis—Temozolomide—brain cancer	0.0011	0.00211	CcSEcCtD
Doxazosin—Somnolence—Procarbazine—brain cancer	0.0011	0.00211	CcSEcCtD
Doxazosin—Cramp muscle—Etoposide—brain cancer	0.0011	0.00211	CcSEcCtD
Doxazosin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00109	0.00209	CcSEcCtD
Doxazosin—ADRA1A—cerebellum—brain cancer	0.00109	0.00846	CbGeAlD
Doxazosin—Hypoaesthesia—Carmustine—brain cancer	0.00109	0.00208	CcSEcCtD
Doxazosin—Decreased appetite—Procarbazine—brain cancer	0.00108	0.00207	CcSEcCtD
Doxazosin—KCNH2—central nervous system—brain cancer	0.00107	0.00835	CbGeAlD
Doxazosin—ADRA2A—midbrain—brain cancer	0.00107	0.00831	CbGeAlD
Doxazosin—Fatigue—Procarbazine—brain cancer	0.00107	0.00205	CcSEcCtD
Doxazosin—Malaise—Hydroxyurea—brain cancer	0.00106	0.00203	CcSEcCtD
Doxazosin—Constipation—Procarbazine—brain cancer	0.00106	0.00203	CcSEcCtD
Doxazosin—Pain—Procarbazine—brain cancer	0.00106	0.00203	CcSEcCtD
Doxazosin—Hepatitis—Temozolomide—brain cancer	0.00105	0.00202	CcSEcCtD
Doxazosin—Leukopenia—Hydroxyurea—brain cancer	0.00105	0.00202	CcSEcCtD
Doxazosin—Visual impairment—Carmustine—brain cancer	0.00105	0.00202	CcSEcCtD
Doxazosin—KCNH2—cerebellum—brain cancer	0.00105	0.00817	CbGeAlD
Doxazosin—Hypoaesthesia—Temozolomide—brain cancer	0.00105	0.00201	CcSEcCtD
Doxazosin—Pharyngitis—Temozolomide—brain cancer	0.00105	0.00201	CcSEcCtD
Doxazosin—ADRA2A—spinal cord—brain cancer	0.00104	0.00811	CbGeAlD
Doxazosin—Bronchospasm—Etoposide—brain cancer	0.00104	0.00199	CcSEcCtD
Doxazosin—Sweating increased—Etoposide—brain cancer	0.00103	0.00197	CcSEcCtD
Doxazosin—Feeling abnormal—Procarbazine—brain cancer	0.00102	0.00196	CcSEcCtD
Doxazosin—Eye disorder—Carmustine—brain cancer	0.00102	0.00196	CcSEcCtD
Doxazosin—Convulsion—Hydroxyurea—brain cancer	0.00102	0.00195	CcSEcCtD
Doxazosin—Visual impairment—Temozolomide—brain cancer	0.00102	0.00195	CcSEcCtD
Doxazosin—Gastrointestinal pain—Procarbazine—brain cancer	0.00101	0.00194	CcSEcCtD
Doxazosin—Flushing—Carmustine—brain cancer	0.00101	0.00194	CcSEcCtD
Doxazosin—Discomfort—Hydroxyurea—brain cancer	0.000988	0.0019	CcSEcCtD
Doxazosin—Neutropenia—Etoposide—brain cancer	0.000986	0.00189	CcSEcCtD
Doxazosin—Eye disorder—Temozolomide—brain cancer	0.000985	0.00189	CcSEcCtD
Doxazosin—Urticaria—Procarbazine—brain cancer	0.000984	0.00189	CcSEcCtD
Doxazosin—Tinnitus—Temozolomide—brain cancer	0.000983	0.00189	CcSEcCtD
Doxazosin—Body temperature increased—Procarbazine—brain cancer	0.000979	0.00188	CcSEcCtD
Doxazosin—Abdominal pain—Procarbazine—brain cancer	0.000979	0.00188	CcSEcCtD
Doxazosin—Flushing—Temozolomide—brain cancer	0.000979	0.00188	CcSEcCtD
Doxazosin—Arrhythmia—Carmustine—brain cancer	0.000975	0.00187	CcSEcCtD
Doxazosin—Alopecia—Carmustine—brain cancer	0.000964	0.00185	CcSEcCtD
Doxazosin—Oedema—Hydroxyurea—brain cancer	0.000959	0.00184	CcSEcCtD
Doxazosin—Mental disorder—Carmustine—brain cancer	0.000956	0.00183	CcSEcCtD
Doxazosin—Infection—Hydroxyurea—brain cancer	0.000953	0.00183	CcSEcCtD
Doxazosin—Malnutrition—Carmustine—brain cancer	0.00095	0.00182	CcSEcCtD
Doxazosin—Chills—Temozolomide—brain cancer	0.000946	0.00182	CcSEcCtD
Doxazosin—Pneumonia—Etoposide—brain cancer	0.000945	0.00181	CcSEcCtD
Doxazosin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000939	0.0018	CcSEcCtD
Doxazosin—ADRA2A—endocrine gland—brain cancer	0.000938	0.0073	CbGeAlD
Doxazosin—Alopecia—Temozolomide—brain cancer	0.000932	0.00179	CcSEcCtD
Doxazosin—Skin disorder—Hydroxyurea—brain cancer	0.000931	0.00179	CcSEcCtD
Doxazosin—Acute coronary syndrome—Etoposide—brain cancer	0.000926	0.00178	CcSEcCtD
Doxazosin—ADRA2A—head—brain cancer	0.000926	0.00721	CbGeAlD
Doxazosin—Mental disorder—Temozolomide—brain cancer	0.000924	0.00177	CcSEcCtD
Doxazosin—Myocardial infarction—Etoposide—brain cancer	0.000921	0.00177	CcSEcCtD
Doxazosin—Back pain—Carmustine—brain cancer	0.000919	0.00176	CcSEcCtD
Doxazosin—Malnutrition—Temozolomide—brain cancer	0.000918	0.00176	CcSEcCtD
Doxazosin—Jaundice—Etoposide—brain cancer	0.000916	0.00176	CcSEcCtD
Doxazosin—Anorexia—Hydroxyurea—brain cancer	0.000914	0.00175	CcSEcCtD
Doxazosin—Hypersensitivity—Procarbazine—brain cancer	0.000913	0.00175	CcSEcCtD
Doxazosin—Dysgeusia—Temozolomide—brain cancer	0.000899	0.00172	CcSEcCtD
Doxazosin—Vision blurred—Carmustine—brain cancer	0.000895	0.00172	CcSEcCtD
Doxazosin—Tremor—Carmustine—brain cancer	0.00089	0.00171	CcSEcCtD
Doxazosin—Asthenia—Procarbazine—brain cancer	0.000889	0.00171	CcSEcCtD
Doxazosin—Back pain—Temozolomide—brain cancer	0.000888	0.0017	CcSEcCtD
Doxazosin—ADRA1A—brain—brain cancer	0.000883	0.00687	CbGeAlD
Doxazosin—Pruritus—Procarbazine—brain cancer	0.000877	0.00168	CcSEcCtD
Doxazosin—Agitation—Carmustine—brain cancer	0.000873	0.00167	CcSEcCtD
Doxazosin—Vision blurred—Temozolomide—brain cancer	0.000865	0.00166	CcSEcCtD
Doxazosin—Tremor—Temozolomide—brain cancer	0.00086	0.00165	CcSEcCtD
Doxazosin—Dyspnoea—Hydroxyurea—brain cancer	0.000855	0.00164	CcSEcCtD
Doxazosin—KCNH2—brain—brain cancer	0.000853	0.00663	CbGeAlD
Doxazosin—Somnolence—Hydroxyurea—brain cancer	0.000852	0.00164	CcSEcCtD
Doxazosin—Ill-defined disorder—Temozolomide—brain cancer	0.000852	0.00163	CcSEcCtD
Doxazosin—Leukopenia—Carmustine—brain cancer	0.00085	0.00163	CcSEcCtD
Doxazosin—Diarrhoea—Procarbazine—brain cancer	0.000848	0.00163	CcSEcCtD
Doxazosin—ADRA2A—central nervous system—brain cancer	0.000845	0.00658	CbGeAlD
Doxazosin—Dyspepsia—Hydroxyurea—brain cancer	0.000844	0.00162	CcSEcCtD
Doxazosin—Agitation—Temozolomide—brain cancer	0.000843	0.00162	CcSEcCtD
Doxazosin—Hypoaesthesia—Etoposide—brain cancer	0.000839	0.00161	CcSEcCtD
Doxazosin—Decreased appetite—Hydroxyurea—brain cancer	0.000834	0.0016	CcSEcCtD
Doxazosin—ABCB1—telencephalon—brain cancer	0.000829	0.00645	CbGeAlD
Doxazosin—Malaise—Temozolomide—brain cancer	0.000828	0.00159	CcSEcCtD
Doxazosin—Fatigue—Hydroxyurea—brain cancer	0.000827	0.00159	CcSEcCtD
Doxazosin—ADRA2A—cerebellum—brain cancer	0.000826	0.00643	CbGeAlD
Doxazosin—Vertigo—Temozolomide—brain cancer	0.000825	0.00158	CcSEcCtD
Doxazosin—Convulsion—Carmustine—brain cancer	0.000823	0.00158	CcSEcCtD
Doxazosin—Leukopenia—Temozolomide—brain cancer	0.000822	0.00158	CcSEcCtD
Doxazosin—Hypertension—Carmustine—brain cancer	0.00082	0.00157	CcSEcCtD
Doxazosin—Constipation—Hydroxyurea—brain cancer	0.00082	0.00157	CcSEcCtD
Doxazosin—Pain—Hydroxyurea—brain cancer	0.00082	0.00157	CcSEcCtD
Doxazosin—Dizziness—Procarbazine—brain cancer	0.000819	0.00157	CcSEcCtD
Doxazosin—Palpitations—Temozolomide—brain cancer	0.000811	0.00156	CcSEcCtD
Doxazosin—Myalgia—Carmustine—brain cancer	0.000809	0.00155	CcSEcCtD
Doxazosin—Chest pain—Carmustine—brain cancer	0.000809	0.00155	CcSEcCtD
Doxazosin—Anxiety—Carmustine—brain cancer	0.000806	0.00155	CcSEcCtD
Doxazosin—Cough—Temozolomide—brain cancer	0.000801	0.00154	CcSEcCtD
Doxazosin—Convulsion—Temozolomide—brain cancer	0.000795	0.00153	CcSEcCtD
Doxazosin—Hypertension—Temozolomide—brain cancer	0.000792	0.00152	CcSEcCtD
Doxazosin—Feeling abnormal—Hydroxyurea—brain cancer	0.00079	0.00152	CcSEcCtD
Doxazosin—Eye disorder—Etoposide—brain cancer	0.000788	0.00151	CcSEcCtD
Doxazosin—Vomiting—Procarbazine—brain cancer	0.000788	0.00151	CcSEcCtD
Doxazosin—Flushing—Etoposide—brain cancer	0.000783	0.0015	CcSEcCtD
Doxazosin—Confusional state—Carmustine—brain cancer	0.000782	0.0015	CcSEcCtD
Doxazosin—Arthralgia—Temozolomide—brain cancer	0.000781	0.0015	CcSEcCtD
Doxazosin—Myalgia—Temozolomide—brain cancer	0.000781	0.0015	CcSEcCtD
Doxazosin—Rash—Procarbazine—brain cancer	0.000781	0.0015	CcSEcCtD
Doxazosin—Dermatitis—Procarbazine—brain cancer	0.00078	0.0015	CcSEcCtD
Doxazosin—Anxiety—Temozolomide—brain cancer	0.000779	0.00149	CcSEcCtD
Doxazosin—Headache—Procarbazine—brain cancer	0.000776	0.00149	CcSEcCtD
Doxazosin—Oedema—Carmustine—brain cancer	0.000775	0.00149	CcSEcCtD
Doxazosin—Discomfort—Temozolomide—brain cancer	0.000772	0.00148	CcSEcCtD
Doxazosin—Infection—Carmustine—brain cancer	0.00077	0.00148	CcSEcCtD
Doxazosin—Dry mouth—Temozolomide—brain cancer	0.000764	0.00147	CcSEcCtD
Doxazosin—Thrombocytopenia—Carmustine—brain cancer	0.000759	0.00146	CcSEcCtD
Doxazosin—Body temperature increased—Hydroxyurea—brain cancer	0.000758	0.00145	CcSEcCtD
Doxazosin—Chills—Etoposide—brain cancer	0.000757	0.00145	CcSEcCtD
Doxazosin—Tachycardia—Carmustine—brain cancer	0.000757	0.00145	CcSEcCtD
Doxazosin—Confusional state—Temozolomide—brain cancer	0.000755	0.00145	CcSEcCtD
Doxazosin—Oedema—Temozolomide—brain cancer	0.000749	0.00144	CcSEcCtD
Doxazosin—Alopecia—Etoposide—brain cancer	0.000746	0.00143	CcSEcCtD
Doxazosin—Infection—Temozolomide—brain cancer	0.000744	0.00143	CcSEcCtD
Doxazosin—Anorexia—Carmustine—brain cancer	0.000739	0.00142	CcSEcCtD
Doxazosin—Nausea—Procarbazine—brain cancer	0.000736	0.00141	CcSEcCtD
Doxazosin—Thrombocytopenia—Temozolomide—brain cancer	0.000733	0.00141	CcSEcCtD
Doxazosin—Skin disorder—Temozolomide—brain cancer	0.000728	0.0014	CcSEcCtD
Doxazosin—CYP2D6—endocrine gland—brain cancer	0.000727	0.00565	CbGeAlD
Doxazosin—Hypotension—Carmustine—brain cancer	0.000724	0.00139	CcSEcCtD
Doxazosin—Hyperhidrosis—Temozolomide—brain cancer	0.000724	0.00139	CcSEcCtD
Doxazosin—Dysgeusia—Etoposide—brain cancer	0.000719	0.00138	CcSEcCtD
Doxazosin—CYP2D6—head—brain cancer	0.000717	0.00558	CbGeAlD
Doxazosin—Anorexia—Temozolomide—brain cancer	0.000714	0.00137	CcSEcCtD
Doxazosin—Back pain—Etoposide—brain cancer	0.00071	0.00136	CcSEcCtD
Doxazosin—Hypersensitivity—Hydroxyurea—brain cancer	0.000706	0.00136	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000706	0.00136	CcSEcCtD
Doxazosin—Muscle spasms—Etoposide—brain cancer	0.000706	0.00136	CcSEcCtD
Doxazosin—Insomnia—Carmustine—brain cancer	0.000701	0.00135	CcSEcCtD
Doxazosin—Paraesthesia—Carmustine—brain cancer	0.000696	0.00134	CcSEcCtD
Doxazosin—ABCB1—gonad—brain cancer	0.000692	0.00538	CbGeAlD
Doxazosin—Dyspnoea—Carmustine—brain cancer	0.000691	0.00133	CcSEcCtD
Doxazosin—Somnolence—Carmustine—brain cancer	0.000689	0.00132	CcSEcCtD
Doxazosin—Asthenia—Hydroxyurea—brain cancer	0.000688	0.00132	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000682	0.00131	CcSEcCtD
Doxazosin—Ill-defined disorder—Etoposide—brain cancer	0.000681	0.00131	CcSEcCtD
Doxazosin—Insomnia—Temozolomide—brain cancer	0.000677	0.0013	CcSEcCtD
Doxazosin—ABCB1—pituitary gland—brain cancer	0.000675	0.00525	CbGeAlD
Doxazosin—Decreased appetite—Carmustine—brain cancer	0.000674	0.00129	CcSEcCtD
Doxazosin—Paraesthesia—Temozolomide—brain cancer	0.000673	0.00129	CcSEcCtD
Doxazosin—ADRA2A—brain—brain cancer	0.000671	0.00522	CbGeAlD
Doxazosin—Dyspnoea—Temozolomide—brain cancer	0.000668	0.00128	CcSEcCtD
Doxazosin—Somnolence—Temozolomide—brain cancer	0.000666	0.00128	CcSEcCtD
Doxazosin—Constipation—Carmustine—brain cancer	0.000663	0.00127	CcSEcCtD
Doxazosin—Pain—Carmustine—brain cancer	0.000663	0.00127	CcSEcCtD
Doxazosin—Malaise—Etoposide—brain cancer	0.000662	0.00127	CcSEcCtD
Doxazosin—Vertigo—Etoposide—brain cancer	0.00066	0.00127	CcSEcCtD
Doxazosin—Dyspepsia—Temozolomide—brain cancer	0.000659	0.00127	CcSEcCtD
Doxazosin—Leukopenia—Etoposide—brain cancer	0.000657	0.00126	CcSEcCtD
Doxazosin—Diarrhoea—Hydroxyurea—brain cancer	0.000656	0.00126	CcSEcCtD
Doxazosin—CYP2D6—central nervous system—brain cancer	0.000655	0.00509	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—brain cancer	0.000651	0.00507	CbGeAlD
Doxazosin—Decreased appetite—Temozolomide—brain cancer	0.000651	0.00125	CcSEcCtD
Doxazosin—Fatigue—Temozolomide—brain cancer	0.000646	0.00124	CcSEcCtD
Doxazosin—Loss of consciousness—Etoposide—brain cancer	0.000646	0.00124	CcSEcCtD
Doxazosin—Cough—Etoposide—brain cancer	0.000641	0.00123	CcSEcCtD
Doxazosin—Constipation—Temozolomide—brain cancer	0.000641	0.00123	CcSEcCtD
Doxazosin—Pain—Temozolomide—brain cancer	0.000641	0.00123	CcSEcCtD
Doxazosin—CYP2D6—cerebellum—brain cancer	0.00064	0.00498	CbGeAlD
Doxazosin—Feeling abnormal—Carmustine—brain cancer	0.000639	0.00123	CcSEcCtD
Doxazosin—Convulsion—Etoposide—brain cancer	0.000636	0.00122	CcSEcCtD
Doxazosin—Hypertension—Etoposide—brain cancer	0.000634	0.00122	CcSEcCtD
Doxazosin—Dizziness—Hydroxyurea—brain cancer	0.000634	0.00122	CcSEcCtD
Doxazosin—Gastrointestinal pain—Carmustine—brain cancer	0.000634	0.00122	CcSEcCtD
Doxazosin—Chest pain—Etoposide—brain cancer	0.000625	0.0012	CcSEcCtD
Doxazosin—Discomfort—Etoposide—brain cancer	0.000618	0.00119	CcSEcCtD
Doxazosin—Feeling abnormal—Temozolomide—brain cancer	0.000617	0.00118	CcSEcCtD
Doxazosin—Abdominal pain—Carmustine—brain cancer	0.000613	0.00118	CcSEcCtD
Doxazosin—Body temperature increased—Carmustine—brain cancer	0.000613	0.00118	CcSEcCtD
Doxazosin—Gastrointestinal pain—Temozolomide—brain cancer	0.000613	0.00118	CcSEcCtD
Doxazosin—Vomiting—Hydroxyurea—brain cancer	0.00061	0.00117	CcSEcCtD
Doxazosin—Rash—Hydroxyurea—brain cancer	0.000605	0.00116	CcSEcCtD
Doxazosin—Confusional state—Etoposide—brain cancer	0.000604	0.00116	CcSEcCtD
Doxazosin—Dermatitis—Hydroxyurea—brain cancer	0.000604	0.00116	CcSEcCtD
Doxazosin—Headache—Hydroxyurea—brain cancer	0.000601	0.00115	CcSEcCtD
Doxazosin—Infection—Etoposide—brain cancer	0.000595	0.00114	CcSEcCtD
Doxazosin—ABCB1—midbrain—brain cancer	0.000595	0.00463	CbGeAlD
Doxazosin—Urticaria—Temozolomide—brain cancer	0.000595	0.00114	CcSEcCtD
Doxazosin—Body temperature increased—Temozolomide—brain cancer	0.000592	0.00114	CcSEcCtD
Doxazosin—Abdominal pain—Temozolomide—brain cancer	0.000592	0.00114	CcSEcCtD
Doxazosin—Thrombocytopenia—Etoposide—brain cancer	0.000587	0.00113	CcSEcCtD
Doxazosin—Tachycardia—Etoposide—brain cancer	0.000585	0.00112	CcSEcCtD
Doxazosin—Skin disorder—Etoposide—brain cancer	0.000582	0.00112	CcSEcCtD
Doxazosin—ABCB1—spinal cord—brain cancer	0.000581	0.00452	CbGeAlD
Doxazosin—Hyperhidrosis—Etoposide—brain cancer	0.000579	0.00111	CcSEcCtD
Doxazosin—Anorexia—Etoposide—brain cancer	0.000571	0.0011	CcSEcCtD
Doxazosin—Hypersensitivity—Carmustine—brain cancer	0.000571	0.0011	CcSEcCtD
Doxazosin—Nausea—Hydroxyurea—brain cancer	0.00057	0.00109	CcSEcCtD
Doxazosin—Hypotension—Etoposide—brain cancer	0.00056	0.00107	CcSEcCtD
Doxazosin—Asthenia—Carmustine—brain cancer	0.000556	0.00107	CcSEcCtD
Doxazosin—Hypersensitivity—Temozolomide—brain cancer	0.000552	0.00106	CcSEcCtD
Doxazosin—Paraesthesia—Etoposide—brain cancer	0.000538	0.00103	CcSEcCtD
Doxazosin—Asthenia—Temozolomide—brain cancer	0.000537	0.00103	CcSEcCtD
Doxazosin—Dyspnoea—Etoposide—brain cancer	0.000534	0.00103	CcSEcCtD
Doxazosin—Somnolence—Etoposide—brain cancer	0.000533	0.00102	CcSEcCtD
Doxazosin—Diarrhoea—Carmustine—brain cancer	0.00053	0.00102	CcSEcCtD
Doxazosin—Pruritus—Temozolomide—brain cancer	0.00053	0.00102	CcSEcCtD
Doxazosin—ABCB1—endocrine gland—brain cancer	0.000523	0.00407	CbGeAlD
Doxazosin—Decreased appetite—Etoposide—brain cancer	0.000521	0.001	CcSEcCtD
Doxazosin—CYP2D6—brain—brain cancer	0.00052	0.00404	CbGeAlD
Doxazosin—Fatigue—Etoposide—brain cancer	0.000517	0.000992	CcSEcCtD
Doxazosin—ABCB1—head—brain cancer	0.000516	0.00402	CbGeAlD
Doxazosin—Dizziness—Carmustine—brain cancer	0.000513	0.000984	CcSEcCtD
Doxazosin—Pain—Etoposide—brain cancer	0.000513	0.000984	CcSEcCtD
Doxazosin—Constipation—Etoposide—brain cancer	0.000513	0.000984	CcSEcCtD
Doxazosin—Diarrhoea—Temozolomide—brain cancer	0.000513	0.000984	CcSEcCtD
Doxazosin—Dizziness—Temozolomide—brain cancer	0.000495	0.000951	CcSEcCtD
Doxazosin—Feeling abnormal—Etoposide—brain cancer	0.000494	0.000948	CcSEcCtD
Doxazosin—Vomiting—Carmustine—brain cancer	0.000493	0.000946	CcSEcCtD
Doxazosin—Gastrointestinal pain—Etoposide—brain cancer	0.00049	0.000941	CcSEcCtD
Doxazosin—Rash—Carmustine—brain cancer	0.000489	0.000938	CcSEcCtD
Doxazosin—Dermatitis—Carmustine—brain cancer	0.000488	0.000937	CcSEcCtD
Doxazosin—Headache—Carmustine—brain cancer	0.000486	0.000932	CcSEcCtD
Doxazosin—Vomiting—Temozolomide—brain cancer	0.000476	0.000914	CcSEcCtD
Doxazosin—Urticaria—Etoposide—brain cancer	0.000476	0.000914	CcSEcCtD
Doxazosin—Abdominal pain—Etoposide—brain cancer	0.000474	0.000909	CcSEcCtD
Doxazosin—Body temperature increased—Etoposide—brain cancer	0.000474	0.000909	CcSEcCtD
Doxazosin—Rash—Temozolomide—brain cancer	0.000472	0.000906	CcSEcCtD
Doxazosin—Dermatitis—Temozolomide—brain cancer	0.000472	0.000906	CcSEcCtD
Doxazosin—ABCB1—central nervous system—brain cancer	0.000471	0.00366	CbGeAlD
Doxazosin—Headache—Temozolomide—brain cancer	0.000469	0.000901	CcSEcCtD
Doxazosin—ABCB1—cerebellum—brain cancer	0.00046	0.00358	CbGeAlD
Doxazosin—Nausea—Carmustine—brain cancer	0.00046	0.000884	CcSEcCtD
Doxazosin—Nausea—Temozolomide—brain cancer	0.000445	0.000854	CcSEcCtD
Doxazosin—Hypersensitivity—Etoposide—brain cancer	0.000442	0.000848	CcSEcCtD
Doxazosin—Asthenia—Etoposide—brain cancer	0.00043	0.000825	CcSEcCtD
Doxazosin—Pruritus—Etoposide—brain cancer	0.000424	0.000814	CcSEcCtD
Doxazosin—Diarrhoea—Etoposide—brain cancer	0.00041	0.000787	CcSEcCtD
Doxazosin—Dizziness—Etoposide—brain cancer	0.000396	0.000761	CcSEcCtD
Doxazosin—Vomiting—Etoposide—brain cancer	0.000381	0.000731	CcSEcCtD
Doxazosin—Rash—Etoposide—brain cancer	0.000378	0.000725	CcSEcCtD
Doxazosin—Dermatitis—Etoposide—brain cancer	0.000378	0.000725	CcSEcCtD
Doxazosin—Headache—Etoposide—brain cancer	0.000376	0.000721	CcSEcCtD
Doxazosin—ABCB1—brain—brain cancer	0.000374	0.00291	CbGeAlD
Doxazosin—Nausea—Etoposide—brain cancer	0.000356	0.000683	CcSEcCtD
Doxazosin—ADRA1B—GPCR downstream signaling—ABR—brain cancer	8.61e-05	0.00167	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—SMO—brain cancer	8.42e-05	0.00164	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—PTCH1—brain cancer	8.42e-05	0.00164	CbGpPWpGaD
Doxazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	8.34e-05	0.00162	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—SHH—brain cancer	8.25e-05	0.0016	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.23e-05	0.0016	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTCH2—brain cancer	8.22e-05	0.0016	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—OR4C12—brain cancer	8.11e-05	0.00158	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—OR14C36—brain cancer	8.11e-05	0.00158	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—TP53—brain cancer	8.11e-05	0.00157	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—PTCH1—brain cancer	7.82e-05	0.00152	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—SMO—brain cancer	7.82e-05	0.00152	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—ABR—brain cancer	7.82e-05	0.00152	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DTX2—brain cancer	7.76e-05	0.00151	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—ABR—brain cancer	7.65e-05	0.00149	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—OR4C12—brain cancer	7.54e-05	0.00146	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—OR14C36—brain cancer	7.54e-05	0.00146	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.31e-05	0.00142	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—IL2—brain cancer	7.28e-05	0.00141	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.17e-05	0.00139	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	7.14e-05	0.00139	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TRPC6—brain cancer	7.12e-05	0.00138	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ABR—brain cancer	7.1e-05	0.00138	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTCH2—brain cancer	7.09e-05	0.00138	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.08e-05	0.00138	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ABR—brain cancer	6.94e-05	0.00135	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DTX2—brain cancer	6.9e-05	0.00134	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HES5—brain cancer	6.87e-05	0.00133	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STRADA—brain cancer	6.67e-05	0.00129	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.58e-05	0.00128	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.57e-05	0.00128	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—TRPC6—brain cancer	6.56e-05	0.00128	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ABR—brain cancer	6.45e-05	0.00125	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DTX2—brain cancer	6.41e-05	0.00124	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.27e-05	0.00122	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—VEGFA—brain cancer	6.18e-05	0.0012	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—SHH—brain cancer	6.18e-05	0.0012	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.02e-05	0.00117	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TRPC6—brain cancer	5.96e-05	0.00116	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTCH2—brain cancer	5.88e-05	0.00114	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—SMO—brain cancer	5.86e-05	0.00114	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PTCH1—brain cancer	5.86e-05	0.00114	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HES5—brain cancer	5.7e-05	0.00111	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ABR—brain cancer	5.56e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STRADA—brain cancer	5.53e-05	0.00107	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—TRPC6—brain cancer	5.45e-05	0.00106	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.42e-05	0.00105	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GLI2—brain cancer	5.37e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VAV1—brain cancer	5.33e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	5.27e-05	0.00102	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTCH2—brain cancer	5.23e-05	0.00102	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP2C9—brain cancer	5.18e-05	0.00101	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—SHH—brain cancer	5.13e-05	0.000997	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.1e-05	0.000991	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HES5—brain cancer	5.06e-05	0.000983	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GLI1—brain cancer	5.05e-05	0.000981	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TRPC6—brain cancer	4.95e-05	0.000961	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—VAV1—brain cancer	4.92e-05	0.000955	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STRADA—brain cancer	4.91e-05	0.000954	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PTCH1—brain cancer	4.86e-05	0.000945	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—SMO—brain cancer	4.86e-05	0.000945	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTCH2—brain cancer	4.86e-05	0.000943	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	4.84e-05	0.00094	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SUFU—brain cancer	4.79e-05	0.00093	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HES5—brain cancer	4.7e-05	0.000914	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—IL2—brain cancer	4.62e-05	0.000898	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GFAP—brain cancer	4.62e-05	0.000897	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ABR—brain cancer	4.62e-05	0.000897	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STRADA—brain cancer	4.57e-05	0.000887	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—SHH—brain cancer	4.56e-05	0.000885	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—TRPC6—brain cancer	4.5e-05	0.000873	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—VAV1—brain cancer	4.47e-05	0.000868	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GLI2—brain cancer	4.46e-05	0.000866	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—BSG—brain cancer	4.4e-05	0.000855	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	4.39e-05	0.000854	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HEY1—brain cancer	4.38e-05	0.000851	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.38e-05	0.00085	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—SMO—brain cancer	4.32e-05	0.000839	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	4.32e-05	0.000839	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—DLL1—brain cancer	4.3e-05	0.000834	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.26e-05	0.000827	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—SHH—brain cancer	4.23e-05	0.000823	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GLI1—brain cancer	4.19e-05	0.000814	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ABR—brain cancer	4.1e-05	0.000797	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TRPC6—brain cancer	4.08e-05	0.000793	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	4.08e-05	0.000793	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—SMO—brain cancer	4.01e-05	0.00078	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	4.01e-05	0.00078	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SUFU—brain cancer	3.97e-05	0.000772	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.96e-05	0.00077	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GLI2—brain cancer	3.96e-05	0.000769	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.93e-05	0.000763	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.89e-05	0.000755	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GFAP—brain cancer	3.83e-05	0.000745	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ABR—brain cancer	3.81e-05	0.00074	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—IDH1—brain cancer	3.78e-05	0.000735	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GLI1—brain cancer	3.72e-05	0.000723	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—VAV1—brain cancer	3.71e-05	0.00072	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GLI2—brain cancer	3.68e-05	0.000715	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP2C9—brain cancer	3.67e-05	0.000712	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SHH—brain cancer	3.65e-05	0.000709	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HEY1—brain cancer	3.64e-05	0.000706	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	3.63e-05	0.000704	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP2C9—brain cancer	3.58e-05	0.000695	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—DLL1—brain cancer	3.56e-05	0.000692	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SUFU—brain cancer	3.53e-05	0.000686	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TRPC6—brain cancer	3.52e-05	0.000684	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.5e-05	0.00068	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.47e-05	0.000673	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SMO—brain cancer	3.46e-05	0.000672	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTCH1—brain cancer	3.46e-05	0.000672	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GLI1—brain cancer	3.46e-05	0.000672	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GFAP—brain cancer	3.41e-05	0.000662	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CG—brain cancer	3.39e-05	0.000658	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP2C9—brain cancer	3.37e-05	0.000655	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	3.37e-05	0.000654	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—VAV1—brain cancer	3.29e-05	0.00064	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SUFU—brain cancer	3.28e-05	0.000637	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HEY1—brain cancer	3.23e-05	0.000627	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—DLL1—brain cancer	3.17e-05	0.000615	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GFAP—brain cancer	3.16e-05	0.000615	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	3.12e-05	0.000607	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—BSG—brain cancer	3.12e-05	0.000606	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—VAV1—brain cancer	3.06e-05	0.000594	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.05e-05	0.000593	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—BSG—brain cancer	3.04e-05	0.000591	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SHH—brain cancer	3.03e-05	0.000589	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HEY1—brain cancer	3e-05	0.000583	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ENO2—brain cancer	2.99e-05	0.000581	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—DLL1—brain cancer	2.94e-05	0.000571	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TRPC6—brain cancer	2.92e-05	0.000568	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTCH1—brain cancer	2.87e-05	0.000558	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SMO—brain cancer	2.87e-05	0.000558	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—BSG—brain cancer	2.87e-05	0.000557	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	2.84e-05	0.000551	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.81e-05	0.000545	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	2.77e-05	0.000538	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.75e-05	0.000534	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SHH—brain cancer	2.69e-05	0.000523	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—IDH1—brain cancer	2.68e-05	0.000521	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VAV1—brain cancer	2.64e-05	0.000513	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—IDH1—brain cancer	2.62e-05	0.000508	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TRPC6—brain cancer	2.6e-05	0.000504	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	2.59e-05	0.000503	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SMO—brain cancer	2.55e-05	0.000496	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTCH1—brain cancer	2.55e-05	0.000496	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SHH—brain cancer	2.5e-05	0.000486	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—IDH1—brain cancer	2.47e-05	0.000479	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TRPC6—brain cancer	2.41e-05	0.000469	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2—brain cancer	2.38e-05	0.000463	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SMO—brain cancer	2.37e-05	0.000461	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTCH1—brain cancer	2.37e-05	0.000461	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	2.35e-05	0.000457	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.31e-05	0.000448	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	2.3e-05	0.000447	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	2.3e-05	0.000446	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HES1—brain cancer	2.27e-05	0.000441	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2—brain cancer	2.2e-05	0.000427	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VAV1—brain cancer	2.19e-05	0.000425	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.18e-05	0.000424	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	2.16e-05	0.00042	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	2.14e-05	0.000416	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ENO2—brain cancer	2.12e-05	0.000412	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SPP1—brain cancer	2.1e-05	0.000407	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	2.09e-05	0.000406	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ENO2—brain cancer	2.07e-05	0.000402	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	2.04e-05	0.000396	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—brain cancer	2.02e-05	0.000393	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2—brain cancer	2e-05	0.000388	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ENO2—brain cancer	1.95e-05	0.000379	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.95e-05	0.000378	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.94e-05	0.000377	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IRS2—brain cancer	1.9e-05	0.000368	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.9e-05	0.000368	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HES1—brain cancer	1.88e-05	0.000366	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—brain cancer	1.82e-05	0.000354	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.81e-05	0.000351	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	1.79e-05	0.000348	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.74e-05	0.000338	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APC—brain cancer	1.68e-05	0.000325	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	1.68e-05	0.000325	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HES1—brain cancer	1.67e-05	0.000325	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.66e-05	0.000322	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.62e-05	0.000315	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.59e-05	0.000309	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.57e-05	0.000306	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000302	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.55e-05	0.0003	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—brain cancer	1.53e-05	0.000297	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—brain cancer	1.53e-05	0.000296	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.000292	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000287	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.47e-05	0.000286	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000279	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.4e-05	0.000272	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.39e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APC—brain cancer	1.39e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—brain cancer	1.37e-05	0.000267	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000266	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RELA—brain cancer	1.31e-05	0.000254	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.3e-05	0.000253	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000252	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.27e-05	0.000246	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—brain cancer	1.24e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.24e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—brain cancer	1.18e-05	0.000229	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.15e-05	0.000223	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—brain cancer	1.15e-05	0.000223	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000223	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.14e-05	0.000221	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.13e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RELA—brain cancer	1.09e-05	0.000211	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.08e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000203	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1e-05	0.000195	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—brain cancer	9.92e-06	0.000193	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—brain cancer	9.79e-06	0.00019	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—brain cancer	9.72e-06	0.000189	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RELA—brain cancer	9.65e-06	0.000187	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—brain cancer	9.59e-06	0.000186	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—brain cancer	9.54e-06	0.000185	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—brain cancer	9.49e-06	0.000184	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	9.45e-06	0.000183	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—brain cancer	9.22e-06	0.000179	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—brain cancer	9.02e-06	0.000175	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RELA—brain cancer	8.97e-06	0.000174	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—brain cancer	8.94e-06	0.000174	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—brain cancer	8.91e-06	0.000173	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—brain cancer	8.69e-06	0.000169	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—brain cancer	8.47e-06	0.000165	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	8.39e-06	0.000163	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—brain cancer	8.32e-06	0.000162	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—brain cancer	8.23e-06	0.00016	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—brain cancer	8.08e-06	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—brain cancer	7.87e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	7.8e-06	0.000151	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—brain cancer	7.65e-06	0.000149	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—brain cancer	7.57e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—brain cancer	7.48e-06	0.000145	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—brain cancer	7.39e-06	0.000143	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—brain cancer	7.31e-06	0.000142	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—brain cancer	6.86e-06	0.000133	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—brain cancer	6.8e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—brain cancer	6.8e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—brain cancer	6.65e-06	0.000129	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—brain cancer	6.31e-06	0.000123	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—brain cancer	6.28e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—brain cancer	6.18e-06	0.00012	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—brain cancer	5.58e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—brain cancer	5.19e-06	0.000101	CbGpPWpGaD
